Granulocyte/macrophage colony-stimulating factor and interleukin-4-induced dendritic cells

Anticancer Research

Volumn 24, Issue 3 A, 2004, Pages 1609-1615

  Hikino, Hajime ^a   Kasono, Keizo ^a   Kanzaki, Masaki ^a   Kai, Toshihiro ^a   Konishi, Fumio ^a   Kawakami, Masanobu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Dendritic cell; GM CSF; IL 4; Immunotherapy

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL LYSATE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; IMMUNE RESPONSE; IMMUNIZATION; INJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; TH2 CELL; TUMOR CELL; TUMOR IMMUNITY;

ANIMALS; CACHEXIA; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 3242655581     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271-296, 1991.
2. Bottomly K: T cells and dendritic cells get intimate [comment]. Science 283: 1124-1125, 1999.
3. Scheicher C, Mehlig M, Zecher R and Reske K: Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor. J Immunol Methods 154: 253-264, 1992.
4. Fields RC, Osterholzer JJ, Fuller JA, Thomas EK, Geraghty PJ and Mule JJ: Comparative analysis of murine dendritic cells derived from spleen and bone marrow. J Immunother 21: 323-339, 1998.
5. Labeur MS, Roters B, Pers B, Mehling A, Luger TA, Schwarz T and Grabbe S: Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 162: 168-175, 1999.
6. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Garcia PM, DeLeo AB and Lotze MT: Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines. Stem Cells 15: 94-103, 1997.
7. Fields RC, Shimizu K and Mulé JJ: Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 95: 9482-9487, 1998.
8. Sato M, Iwakabe K, Kimura S and Nishimura T: Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines. Immunol Lett 67: 63-68, 1999.
9. Scott P and Kaufmann SH: The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 12: 346-348, 1991.
10. Bloom BR, Salgame P and Diamond B: Revisiting and revising suppressor T cells. Immunol Today 13: 131-136, 1992.
11. Ghosh P, Komschlies KL, Cippitelli M, Longo DL, Subleski J, Ye J, Sica A, Young HA, Wiltrout RH and Ochoa AC: Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth. J Natl Cancer Inst 87: 1478-1483, 1995.
12. Maeda H and Shiraishi A: TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol 156: 73-78, 1996.
13. Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, Ohta A, Koda T and Nishimura S: The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol 46 Suppl: S52-61, 2000.
14. Nishimura T, Santa K, Yahata T, Sato N, Ohta A, Ohmi Y, Sato T, Hozumi K and Habu S: Involvement of IL-4-producing Vbeta8.2+ CD4+ CD62L- CD45RB- T cells in non-MHC gene-controlled predisposition toward skewing into T helper type-2 immunity in BALB/c mice. J Immunol 158: 5698-5706, 1997.
15. Soda K, Kawakami M, Kashii A and Miyata M: Manifestations of cancer cachexia induced by colon 26 adenocarcinoma are not fully ascribable to interleukin-6. Int J Cancer 62: 332-336, 1995.
16. Soda K, Kawakami M, Takagi S, Kashii A and Miyata M: Splenectomy before tumor inoculation prolongs the survival time of cachectic mice. Cancer Immunol Immunother 41: 203-209, 1995.
17. Fox BA, Spiess PJ, Kasid A, Puri R, Mulé JJ, Weber JS and Rosenberg SA: In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. J Biol Response Mod 9: 499-511, 1990.
18. Schmidt W, Steinlein P, Buschle M, Schweighoffer T, Herbst E, Mechtler K, Kirlappos H and Birnstiel ML: Transloading of tumor cells with foreign major histocompatibility complex class I peptide ligand: a novel general strategy for the generation of potent cancer vaccines. Proc Natl Acad Sci USA 93: 9759-9763, 1996.
19. Corbett TH, Griswold DP, Roberts BJ, Peckham JC and Schabel FM: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434-2439, 1975.
20. Fujimoto OK, Tamura S, Mori K, Tanaka Y and Ishitsuka H: Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma. Int J Cancer 61: 522-528, 1995.
21. Miyagi T and Kimura H: Phenotype and function of dendritic cells derived from rat bone marrow cell cultures. Transplant Proc 27: 1568-1570, 1995.
22. Decker T and Lohmann MM: A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115: 61-69, 1988.
23. Hadzantonis M and O'Neill H: Review: dendritic cell immunotherapy for melanoma. Cancer Biother Radiopharm 14: 11-22, 1999.
24. Gilboa E, Nair SK and Lyerly HK: Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunol Immunother 46: 82-87, 1998.
25. Ishii Y, Matsuura A, Takami T, Uede T, Ibayashi Y, Uede T, Imamura M, Kikuchi K and Kikuchi Y: Lymphoid cell subpopulations infiltrating into autologous rat tumors undergoing rejection. Cancer Res 44: 4053-4058, 1984.
26. DeMatos P, Abdel WZ, Vervaert C and Seigler HF: Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice. Cell Immunol 185: 65-74, 1998.
27. Bennett SR, Carbone FR, Karamalis F, Miller JF and Heath WR: Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 186: 65-70, 1997.
28. Porgador A, Snyder D and Gilboa E: Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156: 2918-2926, 1996.
29. Rincon M, Anguita J, Nakamura T, Fikrig E and Flavell RA: Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 185: 461-469, 1997.
30. Cahlin C, Korner A, Axelsson H, Wang W, Lundholm K and Svanberg E: Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 BI background and eicosanoid-dependent cachexia. Cancer Res 60: 5488-5493, 2000.
31. Maldonado Lupez R, De Smedt T, Michel P, Godfroid J, Pajak B, Heirman C, Thielemans K, Leo O, Urbain J and Moser M: CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189: 587-592, 1999.
32. Sato M, Iwakabe K, Ohta A, Sekimoto M, Nakui M, Koda T, Kimura S and Nishimura T: Functional heterogeneity among bone marrow-derived dendritic cells conditioned by T(h)1- and T(h)2-biasing cytokines for the generation of allogeneic cytotoxic T lymphocytes. Int Immunol 12: 335-342, 2000.
33. Paul WE and Seder RA: Lymphocyte responses and cytokines. Cell 76: 241-251,1994.
34. Seo N and Tokura Y: Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles. J Interferon Cytokine Res 19: 555-561, 1999.
35. Ohta A, Sato N, Yahata T, Ohmi Y, Santa K, Sato T, Tashiro H, Habu S and Nishimura T: Manipulation of Th1/Th2 balance in vivo by adoptive transfer of antigen-specific Th1 or Th2 cells. J Immunol Methods 209: 85-92, 1997.
36. Mori K, Fujimoto OK, Ishikawa T, Sekiguchi F, Ishitsuka H and Tanaka Y: Murine interleukin-12 prevents the development of cancer cachexia in a murine model. Int J Cancer 67: 849-855, 1996.